U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug…

Read More
Sudafed Sinus 12 Hour Relief Tablets

Sudafed Sinus 12 Hour Relief Tablets

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SUDAFED® SINUS 12 HOUR RELIEF TABLETS Pseudoephedrine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SUDAFED® Sinus 12 Hour…

Read More
APO-Sotalol

APO-Sotalol

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-SOTALOL TABLETS Sotalol hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about sotalol. It does not contain all the available…

Read More